Electromedical & Electrotherapeutic Apparatus · SIC 3845

Stereotaxis, Inc.

STXS

Watch

Latest revenue

$6.3M

as of 2026-03-31

Latest net income

$-5.9M

as of 2026-03-31

Net margin

-93.2%

as of 2026-03-31

Price · 5Y

-24.9% / yr 38.7 pts / yr vs S&P 500 76.1% total
Compare:

Live market

delayed ≤15 min
$1.92
1.05%
Market cap
$187.7M
Enterprise value
$187.7M
P/E (trailing)
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$3.59
52-wk low
$1.70
Beta
Shares out
97.7M

5-year trend

About STXS

Business description and risk factors will appear here once STXS's latest filing is fully ingested.

Profitability

Gross margin

52.7%

2.7%

Operating margin

-68.3%

25.7%

Net margin

-66.8%

25.2%

Return on equity

-160.5%

59.4%

Return on assets

-41.4%

19.5%

Leverage

Debt / equity

2.88×

57.0%

Debt / assets

74.2%

14.7%

Earnings tracker

QuarterRevenueYoYNet incomeYoYNet margin

Q1 2026

2026-03-31

$6.3M-15.8%$-5.9M-0.7%-93.2%

Q4 2025

2025-12-31

$8.6M+36.3%$-5.5M+26.4%-64.0%

Q3 2025

2025-09-30

$7.5M-18.8%$-6.5M-4.4%-86.6%

Q2 2025

2025-06-30

$8.8M+95.4%$-3.8M+34.4%-43.5%

Q1 2025

2025-03-31

$7.5M+8.6%$-5.8M-29.2%-77.9%

Q4 2024

2024-12-31

$6.3M$-7.5M-118.5%

Q3 2024

2024-09-30

$9.2M+17.9%$-6.2M-15.3%-67.3%

Q2 2024

2024-06-30

$4.5M-42.7%$-5.8M-17.7%-129.6%

Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.

Industry trend

Electromedical & Electrotherapeutic Apparatus · SIC 3845

No data yet for industry average

Your notes

Keep private notes on STXS — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

Insider buying

$66.6K

Insider selling

$0

Net activity

+$66.6K

Distinct insiders

1

Open-market trades over the last 365 days.

Recent transactions

DateInsiderTypeSharesPriceValue
2025-11-17

Paul J Isaac

Director

Purchase10,000$2.18$21.8K
2025-11-14

Paul J Isaac

Director

Purchase20,000$2.24$44.8K

Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.

Who owns STXS

Institutional value

$32.5M

Total shares held

17.7M

Distinct holders

70

-34 vs prior

As of

2026-03-31

Prior: 2025-12-31

Filers with $100M+ AUM disclose holdings 45 days after quarter end.

Top institutional holders

#ManagerSharesValueQoQ changeAction
1BlackRock, Inc.4.0M$7.3M-68.3K (-1.7%)Trimmed
2VANGUARD CAPITAL MANAGEMENT LLC3.0M$5.5MNew
3Arbiter Partners Capital Management LLC2.9M$5.3M+0 (+0.0%)No change
4ESSEX INVESTMENT MANAGEMENT CO LLC1.6M$2.9M+28.1K (+1.8%)Added
5Warberg Asset Management LLC1.1M$2.0M-13.5K (-1.2%)Trimmed
6AlphaCentric Advisors LLC600.0K$1.1M+0 (+0.0%)No change
7Bank Julius Baer & Co. Ltd, Zurich540.5K$994.6KNew
8VANGUARD FIDUCIARY TRUST CO529.9K$975.0KNew
9SEI INVESTMENTS CO518.9K$954.7K+270.4K (+108.9%)Added
10Sequoia Financial Advisors, LLC380.7K$700.4KNew
11VANGUARD PORTFOLIO MANAGEMENT LLC368.6K$678.3KNew
12PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.237.5K$437.0K-663.8K (-73.6%)Trimmed
13UBS Group AG237.3K$436.6K+11.7K (+5.2%)Added
14Independent Advisor Alliance201.0K$369.8K+2.6K (+1.3%)Added
15Bank of New York Mellon Corp196.0K$360.6K-7.9K (-3.9%)Trimmed
16ENVESTNET ASSET MANAGEMENT INC135.8K$249.8K-29.9K (-18.1%)Trimmed
17RHUMBLINE ADVISERS132.4K$243.5K-1.4K (-1.0%)Trimmed
18Kovack Advisors, Inc.108.9K$201.5K-170.5K (-61.0%)Trimmed
19Leonteq Securities AG75.0K$138.0K+0 (+0.0%)No change
20Nuveen, LLC74.0K$136.1K+0 (+0.0%)No change

Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.

Top questions investors are asking

Coming once STXS's latest filing finishes processing.